摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-乙氧基-1-萘甲酰氯 | 824430-42-4

中文名称
4-乙氧基-1-萘甲酰氯
中文别名
——
英文名称
4-ethoxy-1-naphthoyl chloride
英文别名
4-ethoxy-1-naphthalenecarbonyl chloride;4-Ethoxynaphthalene-1-carbonyl chloride;4-ethoxynaphthalene-1-carbonyl chloride
4-乙氧基-1-萘甲酰氯化学式
CAS
824430-42-4
化学式
C13H11ClO2
mdl
——
分子量
234.682
InChiKey
OHMSYGKSTBKFJP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4
  • 重原子数:
    16
  • 可旋转键数:
    3
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.15
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:65fa473b22b2614cf4bc13df6e32e28c
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-乙氧基-1-萘甲酰氯dichloro(pentamethylcyclopentadienyl)rhodium (III) dimer三氯乙酸铯potassium carbonate 作用下, 以 乙酸乙酯1,2-二氯乙烷 为溶剂, 反应 26.0h, 生成 3-(diphenylmethylene)-5-ethoxy-2-(p-tolyl)-2,3-dihydro-1H-benzo[e]isoindol-1-one
    参考文献:
    名称:
    Rh-Catalyzed annulations of N-methoxybenzamides with ketenimines: synthesis of 3-aminoisoindolinones and 3-diarylmethyleneisoindolinones with strong aggregation induced emission properties
    摘要:
    铑催化的烯胺与N-甲氧基苯甲酰胺的C-H活化/环化反应生成了3-氨基异吲哚啉-1-酮和3-(二芳基亚甲基)异吲哚啉-1-酮。
    DOI:
    10.1039/c6cc05456k
  • 作为产物:
    描述:
    1-乙氧基萘氢氧化钾三氯化铝氯化亚砜 作用下, 以 1,2-二氯乙烷二乙二醇 为溶剂, 反应 14.25h, 生成 4-乙氧基-1-萘甲酰氯
    参考文献:
    名称:
    Structure–activity relationships for 1-alkyl-3-(1-naphthoyl)indoles at the cannabinoid CB1 and CB2 receptors: steric and electronic effects of naphthoyl substituents. New highly selective CB2 receptor agonists
    摘要:
    In an effort to improve indole-based CB2 cannabinoid receptor ligands and also to develop SAR for both the CB1 and CB2 receptors, 47 indole derivatives were prepared and their CB1 and CB2 receptor affinities were determined. The indole derivatives include 1-propyl- and 1-pentyl-3-(1-naphthoyl)indoles both with and without a 2-methyl substituent. Naphthoyl substituents include 4- and 7-alkyl groups as well as 2-, 4-, 6-, 7-methoxy and 4-ethoxy groups. The effects of these substituents on receptor affinities are discussed and structure-activity relationships are presented. In the course of this work three new highly selective CB2 receptor agonists were identified, 1-propyl-3-(4-methyl-1-naphthoylindole (JWH-120), 1-propyl-2-methyl-3-(6-methoxy-1-naphthoylindole (JWH-151), and 1-pentyl-3-(2-methoxy-1-naphthoylindole (JWH-267). GTPgammaS assays indicated that JWH-151 is a full agonist at CB2, while JWH-120 and JWH-267 are partial agonists. Molecular modeling and receptor docking studies were carried out on a set of 3-(4-propyl-1-naphthoyl)indoles, a set of 3-(6-methoxy-1-naphthoyl)indoles and the pair of N-pentyl-3-(2-methoxy-1-naphthoyl)indoles. Docking studies indicated that the CB1 receptor affinities of these compounds were consistent with their aromatic stacking interactions in the aromatic microdomain of the CB1 receptor. (C) 2004 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2004.09.050
点击查看最新优质反应信息

文献信息

  • [EN] THERAPEUTIC COMPOUNDS: PYRIDINE AS SCAFFOLD<br/>[FR] COMPOSES THERAPEUTIQUES DANS LESQUELS LA PYRIDINE EST UTILISEE COMME SQUELETTE
    申请人:ASTRAZENECA AB
    公开号:WO2005115986A1
    公开(公告)日:2005-12-08
    Compounds of formulas I, IA, and IB or IC or pharmaceutically acceptable salts thereof: wherein A, A1, A2, A3, A4, R2, R3, R4 and n are as defined in the specifications well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    其中A、A1、A2、A3、A4、R2、R3、R4和n的化合物的公式I、IA和IB或IC或其药学上可接受的盐:其中A、A1、A2、A3、A4、R2、R3、R4和n的定义如规范中所述,以及包括这些化合物的盐和药物组合物已经准备好。它们在治疗中很有用,特别是在疼痛管理中。
  • Therapeutic Compounds: Pyridine as Scaffold
    申请人:Amin Kosrat
    公开号:US20070225292A1
    公开(公告)日:2007-09-27
    Compounds of formula I or pharmaceutically acceptable salts thereof: wherein R 1 , R 2 , R 3 , R 4 , n and A are as defined in the specification as well as salts and pharmaceutical compositions including the compounds are prepared. They are useful in therapy, in particular in the management of pain.
    式I的化合物或其药学上可接受的盐:其中R1,R2,R3,R4,n和A的定义如规范中所述,以及包括该化合物的盐和制备的药物组合物。它们在治疗中有用,特别是在疼痛管理方面。
  • 10.1021/acs.orglett.4c01805
    作者:Li, Hao-Yuan、Niu, Xiaoying、Zhang, Shan-Shan、Shen, Shigang、Meng, Qing-Yuan、Yang, Xiu-Long
    DOI:10.1021/acs.orglett.4c01805
    日期:——
    Here, we explore a dehydrogenative 6π photocyclization method for N-substituted naphthalene carboxamides, which can be conducted in air. This method employs DMSO as both the reaction solvent and oxidant while also stabilizing the excited state of the substrate. Furthermore, the addition of photosensitizer enables the reaction to proceed under a 440–445 nm LED source via energy transfer. The proposed
    在这里,我们探索了一种N-取代萘甲酰胺的脱氢6π光环化方法,该方法可以在空气中进行。该方法采用DMSO作为反应溶剂和氧化剂,同时稳定底物的激发态。此外,光敏剂的添加使反应能够在 440-445 nm LED 光源下通过能量转移进行。所提出的机制最初通过 DFT 计算得到验证。
  • THERAPEUTIC COMPOUNDS: PYRIDINE AS SCAFFOLD
    申请人:AstraZeneca AB
    公开号:EP1756060A1
    公开(公告)日:2007-02-28
  • DERIVES DE 1 ,2,4-TRIAZINES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE HUMAINE
    申请人:PIERRE FABRE MEDICAMENT
    公开号:EP1856065A1
    公开(公告)日:2007-11-21
查看更多